-
Mashup Score: 3
Belumosudil elicited sustained responses and generated no new safety signals in patients with chronic graft-vs-host disease.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Simulation-based education can improve health care professionals’ understanding and confidence regarding the treatment of patients with CAR T-cell therapy.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Orca-T demonstrated positive impacts on relapse-free survival and overall survival vs PTCy-based HSCT in acute leukemias and myelodysplastic syndrome.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD @DrCCutler @DanaFarber @theebmt #EBMT24 #oncology https://t.co/BNFp8db9Xy